| Review of clinical data with Paccocath- Coated Balloon Catheters. | |
| | |
MedLine Citation:
|
PMID: 21983304 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The use of drug-coated balloons (DCB) for preventing restenosis in both coronary and peripheral arteries has received increasing attention. The first successful clinical outcomes in inhibiting restenosis have been reported for paclitaxel-coated balloons. Paclitaxel is a lipophilic substance characterized by rapid intracellular uptake and irreversible binding to microtubules. In this way, paclitaxel alters the cell structure, ultimately reducing proliferation, migration, and signaling. These properties make paclitaxel a very potent antiproliferative drug. Paclitaxel admixed to a small amount of the hydrophilic X-ray contrast medium iopromide (Ultravist™) emerged as a very effective coating matrix from numerous in vitro and in vivo experiments and has been denoted as Paccocath™. The randomized controlled ISR I/II-, Thunder- and FEMPAC studies have been conducted using Paccocath™ balloons. Late lumen loss as the primary endpoint at 6 months proved to be statistically significantly reduced in the coated balloon groups in coronary and peripheral arteries. The slightly modified coating on the SeQuent™ Please balloons (B.Braun, Melsungen, Germany) has been clinically studied in the PEPCAD (Paclitaxel-Eluting PTCA-Catheter in Coronary Artery Disease) clinical trial program. Cotavance™ balloons (MEDRAD Inc, Minneapolis, USA) are also coated with the Paccocath™ formulation. In this review we first outline the development of Paccocath™ balloons to then provide an overview of the clinical results obtained with the modified coating. Furthermore we examine possible mechanism of action by which single administration of an antiproliferative drug dose using paclitaxel-coated balloons inhibits restenosis. |
| | |
Authors:
|
B Schnorr; U Speck; B Scheller |
Related Documents
:
|
3139844 - Late-onset acid maltase deficiency associated with intracranial aneurysm. 10507394 - Adenosine-induced transient asystole for management of a basilar artery aneurysm. case ... 10659014 - Clinical presentation and management of giant anterior communicating artery region aneu... 3763134 - The nasal junction scotoma in giant aneurysms. 3139844 - Late-onset acid maltase deficiency associated with intracranial aneurysm. 10507394 - Adenosine-induced transient asystole for management of a basilar artery aneurysm. case ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Minerva cardioangiologica Volume: 59 ISSN: 0026-4725 ISO Abbreviation: Minerva Cardioangiol Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-10-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0400725 Medline TA: Minerva Cardioangiol Country: Italy |
Other Details:
|
Languages: eng Pagination: 431-45 Citation Subset: IM |
Affiliation:
|
Department of Radiology, Experimental Radiology, Charité, University Hospital, Berlin, Germany - beatrix.schnorr@charite.de. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Update on transcatheter aortic valve implantation registries and studies.
Next Document: Titanium-nitride-oxide-coated Titan-2 bioactive coronary stent: a new breakthrough in interventional...